European Union (EU) regulators have delayed a decision to give approval for Novavax’s (NVAX.O) variant-tailored COVID-19 vaccine, the Financial Times said on Sunday.
The European Medicines Agency (EMA), which was due to approve the updated vaccine last Friday has requested more information from the company, the FT report added.
Comments closedThe US Department of Health and Human Services (HHS) today announced more than $500 million more in funding through its Project NextGen program to speed the development of new vaccines and treatments for COVID-19.
Comments closedFlorida will have to provide COVID-19 data to the public again after a former Democratic state representative settled a lawsuit with Republican Gov. Ron DeSantis’ administration over the decision two years ago to stop posting information on the virus’ spread online.
Comments closedSome doctors are calling for more preventative measures to protect vulnerable patients in medical settings.
Comments closedVaccinologist Peter Hotez explains how the movement to oppose science and scientists has gained power.
Comments closedThe groundbreaking research of Linsey Marr, an aerosols expert and professor of civil and environmental engineering at Virginia Tech, showed that the SARS-CoV-2 virus is airborne as opposed to traveling in large droplets that fall with gravity.
Comments closedThe Food and Drug Administration announced Tuesday it had authorized Novavax’s updated COVID-19 vaccine, adding a third option for Americans ages 12 and older looking for a new shot this fall and winter.
Comments closedThe pandemic has been lucrative for anti-vaccine groups. The two most influential in the United States saw their revenues more than double between 2020 and 2021. Although they are officially non-profit organizations, one of them was able to pay its director a salary of half a million dollars a year.
Comments closedSARS-CoV-2, the virus that causes COVID-19, can directly infect the arteries of the heart and cause the fatty plaque inside arteries to become highly inflamed, increasing the risk of heart attack and stroke, according to a study funded by the National Institutes of Health. The findings, published in the journal Nature Cardiovascular Research, may help explain why certain people who get COVID-19 have a greater chance of developing cardiovascular disease, or if they already have it, develop more heart-related complications.
Comments closedLong COVID patients have clear differences in immune and hormone function from patients without the condition, according to a new study led by the Icahn School of Medicine at Mount Sinai and Yale School of Medicine.
The research, published in the September 25 issue of Nature, is the first to show specific blood biomarkers that can accurately identify patients with long COVID.
Comments closedIn a groundbreaking development, Arizonans can now apply for worker’s compensation if they contract COVID-19 while on the job. This landmark decision stems from a widow’s determined fight to secure worker’s compensation following her husband’s tragic demise due to COVID-19.
Court documents unequivocally state that if someone contracts COVID-19 at their workplace, they are entitled to file for worker’s compensation. An essential detail to note is that if a worker succumbs to the virus, their next of kin will receive financial support.
Comments closedAmid an uptick in Covid infections, administrators, staff and patients are divided over the need for masks in health care settings.
Comments closedCovid-19 hospitalizations have been on the rise in the United States for months, with weekly admissions now more than triple what they were two months ago. Seniors have the highest rates of Covid hospitalizations by far, but hospitalizations among children — especially among those younger than 5 — are rising fast.
Comments closedThe Covid-19 pandemic eroded trust in science. The 2024 election, public health officials fear, may make it worse.
Comments closedThe US government will relaunch a program to provide free Covid-19 home tests to Americans, US Department of Health and Human Services said Wednesday.
Comments closedA Biden administration that vowed to restore Americans’ faith in public health has grown increasingly paralyzed over how to combat the resurgence in vaccine skepticism.
Comments closedA pediatrician, author and co-inventor of a low-cost COVID-19 vaccine warns that the anti-vaccine movement has morphed into a political force that threatens the world’s gains against deadly childhood infections like measles.
Comments closedNurses, researchers and workplace safety officers worry new guidelines from the Centers for Disease Control and Prevention might reduce protection against the coronavirus and other airborne pathogens in hospitals.
Comments closed